IP Library Granted Patent US 12,023,063
Granted Patent B2
US 12,023,063 · App. 18/233,406 · Granted Jul 2, 2024

Cellulite treatment apparatus

Inventors: Jonathan Podmore (San Carlos, CA); Earl Bright, II (Sunnyvale, CA); Joshua Makower (Los Altos Hills, CA); Pablo Acosta (Newark, CA)
Assignee: Revelle Aesthetics, Inc.
A61B17/320016A61B1/06A61B2017/00747A61B2017/00792
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,023,063
App. No.
18/233,406
Granted
Jul 2, 2024
Kind
B2
Abstract

Systems and methods for treating cellulite including an apparatus that applies or a method involving separating septa to eliminate or reduce the appearance of cellulite. In one approach, an interventional tool is placed between tissue layers to engage and treat septa connecting tissue layers between which fat deposits are contained.

Claims (12)

1. A cellulite treatment apparatus for treating expressions of cellulite on a patient's skin associated with a septa treatment site, comprising:

a handle;

a shaft longitudinally extending from the handle, the shaft sized and shaped to be inserted within tissue and to be advanced between tissue layers to the septa treatment site without assistance from tissue stabilizing structure applied to the patient's skin; and

a septa engaging and cutting assembly at a distal portion of the shaft, the septa engaging and cutting assembly including linkages that project laterally from the shaft;

an actuator on the handle configured to actuate the septa engaging and cutting assembly, wherein the actuator is configured to position the septa engaging and cutting assembly in at least a retracted position, a septa tensioning position where the septa engaging and cutting assembly is positioned to apply tension to septa in a direction parallel to the shaft when the linkages are substantially aligned, and a septa disruption position where the linkages are converted to present a cutting structure.

2. The cellulite treatment apparatus of claim 1 , further comprising a transillumination structure.

3. The apparatus of claim 2 , wherein the transillumination structure is embodied in a light positioned along a distal portion of the shaft.

4. The apparatus of claim 3 , wherein the light is one or more of a LED or a lightguide.

5. The apparatus of claim 1 , wherein the septa engaging and cutting assembly includes a side opening hook.

6. The apparatus claim 1 , wherein the septa engaging and cutting assembly includes an electrode providing selective cautery structure or energy transmitting structure.

7. The apparatus claim 1 , wherein the septa engaging and cutting assembly is sized and shaped to test septa to determine whether tested septa is associated with an expression of cellulite and to stretch, cut, slice or otherwise disrupt septa associated with the expression of cellulite.

8. The apparatus of claim 1 , wherein the septa engaging and cutting assembly comprises a first link rotatably attached to a second link and a drive shaft attached to the first link, the first link, the second link and the drive draft being contained within the shaft, wherein manipulation of the drive shaft causes the first link and second link to project laterally from the shaft.

Continuity (8)
Continuation 17154232 · Jan 21, 2021
Continuation In Part PCTUS2019042871 · Jul 22, 2019
Provisional Application 62825447 · Mar 28, 2019
Provisional Application 62802368 · Feb 7, 2019
Provisional Application 62798515 · Jan 30, 2019
Provisional Application 62736016 · Sep 25, 2018
Provisional Application 62702314 · Jul 23, 2018
Related Publication 20230380854A1 · Nov 30, 2023
Cited By (1)
US 12,588,923